SG11201408163VA - Modified fibronectin fragments or variants and uses thereof - Google Patents

Modified fibronectin fragments or variants and uses thereof

Info

Publication number
SG11201408163VA
SG11201408163VA SG11201408163VA SG11201408163VA SG11201408163VA SG 11201408163V A SG11201408163V A SG 11201408163VA SG 11201408163V A SG11201408163V A SG 11201408163VA SG 11201408163V A SG11201408163V A SG 11201408163VA SG 11201408163V A SG11201408163V A SG 11201408163VA
Authority
SG
Singapore
Prior art keywords
international
taiwan
street
june
title
Prior art date
Application number
SG11201408163VA
Other languages
English (en)
Inventor
Woei-Jer Chuang
Chang Yung-Sheng
Original Assignee
Dcb Usa Llc
Univ Nat Cheng Kung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dcb Usa Llc, Univ Nat Cheng Kung filed Critical Dcb Usa Llc
Publication of SG11201408163VA publication Critical patent/SG11201408163VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Prostheses (AREA)
SG11201408163VA 2012-06-07 2013-06-07 Modified fibronectin fragments or variants and uses thereof SG11201408163VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261656671P 2012-06-07 2012-06-07
PCT/US2013/044699 WO2013185027A2 (en) 2012-06-07 2013-06-07 Modified fibronectin fragments or variants and uses thereof

Publications (1)

Publication Number Publication Date
SG11201408163VA true SG11201408163VA (en) 2015-01-29

Family

ID=49712865

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201408163VA SG11201408163VA (en) 2012-06-07 2013-06-07 Modified fibronectin fragments or variants and uses thereof

Country Status (14)

Country Link
US (1) US9969791B2 (pt)
EP (1) EP2859113A4 (pt)
JP (1) JP6297543B2 (pt)
KR (1) KR20150041619A (pt)
CN (1) CN104968796A (pt)
AU (1) AU2013271445B2 (pt)
BR (1) BR112014030716A2 (pt)
CA (1) CA2876135A1 (pt)
IL (1) IL236098A0 (pt)
IN (1) IN2015MN00027A (pt)
MX (1) MX2014015028A (pt)
SG (1) SG11201408163VA (pt)
TW (1) TWI580692B (pt)
WO (1) WO2013185027A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6297543B2 (ja) * 2012-06-07 2018-03-20 ナショナル チェン クン ユニバーシティー 修飾フィブロネクチンフラグメント又はバリアント及びその使用
WO2015103643A2 (en) * 2014-01-06 2015-07-09 The General Hospital Corporation Integrin antagonists
EP3313869B1 (en) * 2015-06-26 2021-02-17 Spiber Technologies AB Cyclic rgd cell-binding motif and uses thereof
JP7174627B2 (ja) 2015-10-23 2022-11-17 ウニフェルシタイト・トゥヴェンテ インテグリン結合ペプチド及びその使用
WO2019165017A1 (en) * 2018-02-23 2019-08-29 The University Of Chicago Methods and composition involving thermophilic fibronectin type iii (fn3) monobodies
US11685717B2 (en) 2018-08-08 2023-06-27 The General Hospital Corporation Polypeptide integrin antagonists
CN111285932B (zh) * 2018-12-10 2023-07-11 武汉禾元生物科技股份有限公司 一种从基因工程水稻种子中分离纯化重组人纤维连接蛋白的方法
CN113092772A (zh) * 2019-12-23 2021-07-09 首都医科大学附属北京世纪坛医院 尿液黏连蛋白亚组sa-2及其多肽片段在过敏性疾病中的应用
CN112941081B (zh) * 2021-04-16 2023-04-21 广州启点生物科技有限公司 一种纤连蛋白突变体及其制备方法与应用
US11723955B1 (en) 2022-05-13 2023-08-15 Allgenesis Biotherapeutics Inc. VEGFR fusion protein pharmaceutical composition
TWI836609B (zh) * 2022-09-16 2024-03-21 國立成功大學 纖維黏蛋白第iii型結構域衍生的蛋白質及其應用
CN117298257A (zh) * 2023-07-14 2023-12-29 杭州恩和生物科技有限公司 人纤连蛋白或其功能片段的用途、筛选方法和试剂盒

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US5753230A (en) * 1994-03-18 1998-05-19 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis
US20050118661A1 (en) * 2002-01-21 2005-06-02 Helen Mardon Fibronectin variants and screening methods
WO2009126349A2 (en) * 2008-01-18 2009-10-15 Burnham Institute For Medical Research Methods and compositions related to internalizing rgd peptides
WO2012082950A2 (en) * 2010-12-14 2012-06-21 University Of Rochester Chimeric fibronectin matrix mimetics and uses thereof
JP6297543B2 (ja) * 2012-06-07 2018-03-20 ナショナル チェン クン ユニバーシティー 修飾フィブロネクチンフラグメント又はバリアント及びその使用

Also Published As

Publication number Publication date
EP2859113A2 (en) 2015-04-15
IL236098A0 (en) 2015-01-29
AU2013271445A1 (en) 2015-01-22
TW201412770A (zh) 2014-04-01
US9969791B2 (en) 2018-05-15
MX2014015028A (es) 2015-08-06
KR20150041619A (ko) 2015-04-16
JP6297543B2 (ja) 2018-03-20
WO2013185027A2 (en) 2013-12-12
JP2015521588A (ja) 2015-07-30
CN104968796A (zh) 2015-10-07
CA2876135A1 (en) 2013-12-12
EP2859113A4 (en) 2016-04-13
US20150218251A1 (en) 2015-08-06
AU2013271445B2 (en) 2016-12-15
BR112014030716A2 (pt) 2018-06-26
TWI580692B (zh) 2017-05-01
IN2015MN00027A (pt) 2015-10-16

Similar Documents

Publication Publication Date Title
SG11201408163VA (en) Modified fibronectin fragments or variants and uses thereof
SG11201408261UA (en) Syringe
SG11201808014SA (en) Compositions, devices, and methods for cell separation
SG11201408750VA (en) NOVEL FUSED PYRIDINE DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS
SG11201809912UA (en) Hybrid carriers for nucleic acid cargo
SG11201803920TA (en) Compounds and compositions useful for treating disorders related to ntrk
SG11201407417VA (en) Encoding and reconstruction of residual data based on support information
SG11201406787TA (en) Rnai-based therapies for cardiomyopathies, muscular dystrophies and laminopathies
SG11201408251SA (en) A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
SG11201805645QA (en) Lsd1 inhibitors
SG11201407427WA (en) Extreme pcr
SG11201407580YA (en) Composition comprising two antibodies engineered to have reduced and increased effector function
SG11201403106SA (en) Anti-phf-tau antibodies and their uses
SG11201500005SA (en) Pyrimidine pyrazolyl derivatives
SG11201407662WA (en) Process for the preparation of treprostinil and derivatives thereof
SG11201408561YA (en) Tunable materials
SG11201407900WA (en) Benzo [c] isoxazoloazepine bromodomain inhibitors and uses thereof
SG11201408821SA (en) Selective pi3k delta inhibitors
SG11201408385TA (en) Methods of detecting diseases or conditions
SG11201408237YA (en) Compound as wnt signaling inhibitor, composition, and use thereof
SG11201407851RA (en) Synthesis of pyrrolo [2, 3 - b] pyridines
SG11201406903SA (en) Cell culture compositions and methods for polypeptide production
SG11201408810TA (en) Methods of treating arthritis
SG11201407729VA (en) Methods for drug screen using zebrafish model and the compounds screened thereform
SG11201407655TA (en) Therapeutic uses of fibroblast growth factor 21 proteins